R211-500
Rat Endothelial Cell Growth Medium (500 ml)
Synonym(s):
Primary Cell Culture Media
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
UNSPSC Code:
12352207
NACRES:
NA.71
form
liquid
Quality Level
shelf life
6 mo.
manufacturer/tradename
Cell Applications, Inc
shipped in
wet ice
storage temp.
2-8°C
General description
All-in-one ready-to-use media
Application
Rat Endothelial Cell Growth Medium (500 ml) has been used to culture primary rat endothelial cells and rat aortic endothelial cells.
Preparation Note
contained in protocol
Analysis Note
Each lot was tested for the ability to support plating, spreading and proliferation
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
动植物来源培养基
This item has
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
If you need assistance, please contact Customer Support
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Gang Xi et al.
Journal of diabetes research, 2019, 6456032-6456032 (2019-05-03)
Hyperglycemia results in inhibition of cleavage of integrin-associated protein (IAP) thereby allowing it to bind to SHPS-1 which results in pathophysiologic changes in endothelial function. This study determined if an anti-rat IAP antibody directed against the SHPS-1 binding site which
Qin Huang et al.
Acta diabetologica, 49(3), 205-214 (2011-05-04)
Endothelial cell (EC) survival is critical in the maintenance of endothelial function as well as in the regulation of angiogenesis and vessel integrity since endothelial dysfunction is the initial lesion of atherosclerosis. The goal of this study was to examine
Molly Wasserman Meyers et al.
Physiological reports, 5(4) (2017-03-01)
Surgical and endovascular therapies for severe atherosclerosis often fail due to the development of neointimal hyperplasia and arterial restenosis. Our objective was to synthesize, characterize, and evaluate the targeting specificity and biocompatibility of a novel systemically injected nanoparticle. We hypothesize
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service